These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 26347918)

  • 1. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Kelbæk H; Høfsten DE; Køber L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; De Backer O; Bang LE; Kofoed KF; Lønborg J; Ahtarovski K; Vejlstrup N; Bøtker HE; Terkelsen CJ; Christiansen EH; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Jensen LO; Clemmensen P; Grande P; Madsen JK; Torp-Pedersen C; Engstrøm T
    Lancet; 2016 May; 387(10034):2199-206. PubMed ID: 27053444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Diletti R; den Dekker WK; Bennett J; Schotborgh CE; van der Schaaf R; Sabaté M; Moreno R; Ameloot K; van Bommel R; Forlani D; van Reet B; Esposito G; Dirksen MT; Ruifrok WPT; Everaert BRC; Van Mieghem C; Elscot JJ; Cummins P; Lenzen M; Brugaletta S; Boersma E; Van Mieghem NM;
    Lancet; 2023 Apr; 401(10383):1172-1182. PubMed ID: 36889333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.
    De Backer O; Lønborg J; Helqvist S; Warnøe J; Kløvgaard L; Holmvang L; Pedersen F; Tilsted HH; Raungaard B; Jørgensen E; Køber L; Høfsten DE; Kelbæk H; Engstrøm T
    EuroIntervention; 2019 Jun; 15(2):172-179. PubMed ID: 30666962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction.
    Smits PC; Abdel-Wahab M; Neumann FJ; Boxma-de Klerk BM; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Ong PJ; Hambrecht R; Angerås O; Richardt G; Omerovic E;
    N Engl J Med; 2017 Mar; 376(13):1234-1244. PubMed ID: 28317428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
    Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S;
    N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial.
    Smits PC; Laforgia PL; Abdel-Wahab M; Neumann FJ; Richardt G; Boxma-de Klerk B; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Frederix GW; Omerovic E
    EuroIntervention; 2020 Jun; 16(3):225-232. PubMed ID: 32250250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
    Sadjadieh G; Engstrøm T; Helqvist S; Høfsten DE; Køber L; Pedersen F; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Kelbæk H; Holmvang L
    EuroIntervention; 2016 Nov; 12(10):1231-1238. PubMed ID: 27866133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; De Bruyne B; Chatellier G; Danchin N;
    N Engl J Med; 2021 Jul; 385(4):297-308. PubMed ID: 33999545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
    Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
    Wang LJ; Han S; Zhang XH; Jin YZ
    BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials.
    Gupta A; Bajaj NS; Arora P; Arora G; Qamar A; Bhatt DL
    Int J Cardiol; 2018 Feb; 252():63-67. PubMed ID: 29249439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
    van Nunen LX; Zimmermann FM; Tonino PA; Barbato E; Baumbach A; Engstrøm T; Klauss V; MacCarthy PA; Manoharan G; Oldroyd KG; Ver Lee PN; Van't Veer M; Fearon WF; De Bruyne B; Pijls NH;
    Lancet; 2015 Nov; 386(10006):1853-60. PubMed ID: 26333474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
    Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
    Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction.
    Ekström K; Nielsen JVW; Nepper-Christensen L; Ahtarovski KA; Kyhl K; Göransson C; Bertelsen L; Ghotbi AA; Kelbæk H; Høfsten DE; Køber L; Schoos MM; Vejlstrup N; Lønborg J; Engstrøm T
    Circ Cardiovasc Imaging; 2021 May; 14(5):e012290. PubMed ID: 33951923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.